Screener
Pelthos Therapeutics PTHS EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Pelthos Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Pelthos Therapeutics’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001919246-26-000070
FAQ
- What is Pelthos Therapeutics's EPS (diluted)?
- Pelthos Therapeutics (PTHS) reported EPS (diluted) of -$3.09 in Q1 2026.
- How has Pelthos Therapeutics's EPS (diluted) changed year-over-year?
- Pelthos Therapeutics's EPS (diluted) increased by 3.7% year-over-year, from -$3.21 to -$3.09.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Pelthos Therapeutics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude